BPC-157 is a synthetic peptide made of 15 amino acids. BPC stands for “body protection compound.” Its sequence is based on part of a larger protein found in human gastric juice, although BPC-157 itself is made in a laboratory.
Most of the published research on BPC-157 comes from a small number of research groups, much of it from one university in Croatia.
Nearly all studies on BPC-157 have been done in laboratory settings and in animals, often in models of tissue injury. Human data are very limited. Large, controlled clinical trials, which are needed to show whether a drug is safe and effective in people, have not been published.
Results in animals often do not carry over to humans. That gap is one reason the FDA requires clinical trials before approving any drug.
Current status: Not FDA-approved.
This means the FDA has not approved BPC-157 as safe and effective for any medical use. No product containing it is an approved medicine in the United States.
BPC-157 is also listed as a prohibited substance in competitive sport under the World Anti-Doping Code. Because it is not an approved drug, the FDA has not reviewed the contents, purity or sterility of products sold under the name.
BPC-157 is sometimes combined with other peptides in blends sold under nicknames. Those blends are not approved either.
Peptide Labs does not sell this compound. This page is general information, not medical advice. Our Peptide Guide exists to explain what these compounds are and how they are regulated, not to supply them.
Anyone with questions about BPC-157 should speak with a licensed healthcare provider, who can explain the current evidence and the legal status in plain terms.
See the full list of compound profiles in the Peptide Guide.